Home › Head and Neck Squamous Cell Carcinoma › NCT05031910

Virtual Reality 3D-Surgery Modeling to Enhance Head and Neck Cancer Surgery Quality

Preoperative Virtual Reality and 3D Pathologic Modeling as Treatment for Head and Neck Squamous Cell Carcinoma

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Diagnosed with cancer of the head and neck (oral cavity, oropharynx, larynx, hypopharynx, T1-T4)
* Receiving treatment at Thomas Jefferson University - Center City by a fellowship-trained HNC surgeon
* Eligible for definitive resection
* Age \> 18
* Provide signed written informed consent document

Exclusion Criteria:

* Impaired judgement or those unable to provide informed consent
* Any factor that would place the patient at increased risk or preclude the individual's full compliance with or completion of the study
* Nasopharyngeal carcinoma
* Contraindications for surgery
* Enrollment in other clinical trial

About the study

This clinical trial studies the use of virtual reality technology and three dimensional surgery (3D-surgery) modeling to enhance current treatments in head and neck cancer surgery. Virtual reality 3D-surgery modeling may improve quality of surgical planning and interdisciplinary communication between surgeons and pathologists during the treatment of head and neck squamous cell cancer and ultimately increase the accuracy of planning, the quality of communication, and maximize the outcome patients with head and neck cancer experience throughout treatment.

What is being tested

• Medical Device Usage and Evaluation (other)
• Best Practice (other)
• Resection (procedure)

Sponsor: Thomas Jefferson University · Participants: 160 · Started: Feb 4, 2022

Contact the study team

• Joseph Curry, MD · Phone: 215-955-6784

Official record on ClinicalTrials.gov — NCT05031910

Locations in the U.S.

Conditions

• Head and Neck Squamous Cell Carcinoma

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.